Making sense of the many treatment options for relapsed MM: cost-effectiveness

There are now many options to treated relapsed/refractory multiple myeloma (MM); however, these drugs can be costly, and access differs between countries and locations. In this interview, Jean-Luc Har... Author: VJHemOnc Added: 05/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts